Cargando…

Is hypoimmunogenic stem cell therapy safe in times of pandemics?

The manipulation of human leukocyte antigens (HLAs) and immune modulatory factors in “universal” human pluripotent stem cells (PSCs) holds promise for immunological tolerance without HLA matching. This paradigm raises concerns should "universal" grafts become virally infected. Furthermore,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matheus, Friederike, Raveh, Tal, Oro, Anthony E., Wernig, Marius, Drukker, Micha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023772/ https://www.ncbi.nlm.nih.gov/pubmed/35334219 http://dx.doi.org/10.1016/j.stemcr.2022.02.014

Ejemplares similares

Generation of universal and hypoimmunogenic human pluripotent stem cells
por: Ye, Qingsong, et al.
Publicado: (2020)

Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells
por: Zhao, Wei, et al.
Publicado: (2020)

Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative Medicine
por: Trionfini, Piera, et al.
Publicado: (2023)

Enhanced survival of hypoimmunogenic otic progenitors following intracochlear xenotransplantation: repercussions for stem cell therapy in hearing loss models
por: Andrade da Silva, Luisa H., et al.
Publicado: (2023)

Promotion of skin wound healing using hypoimmunogenic epidermal cell sheets
por: Zhao, Hongqing, et al.
Publicado: (2023)

Development of Wheat With Hypoimmunogenic Gluten Obstructed by the Gene Editing Policy in Europe
por: Jouanin, Aurélie, et al.
Publicado: (2018)

Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application
por: Kitano, Yuko, et al.
Publicado: (2022)

Maintenance of Hypoimmunogenic Features via Regulation of Endogenous Antigen Processing and Presentation Machinery
por: An, Ju-Hyun, et al.
Publicado: (2022)

Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity
por: Chen, Yifan, et al.
Publicado: (2023)

The Safety of Embryonic Stem Cell Therapy Relies on Teratoma Removal
por: Tang, Chad, et al.
Publicado: (2012)

Developing Hypoimmunogenic Human iPSC‐Derived Oligodendrocyte Progenitor Cells as an Off‐The‐Shelf Cell Therapy for Myelin Disorders
por: Feng, Lizhao, et al.
Publicado: (2023)

The malignant niche: safe spaces for toxic stem cell marketing
por: Sipp, Douglas
Publicado: (2017)

A Call for Action to Safely Deliver Oral Health Care during and Post COVID-19 Pandemic
por: Farronato, Marco, et al.
Publicado: (2020)

CT colonography’s role in the COVID-19 pandemic: a safe(r), socially distanced total colon examination
por: Moreno, Courtney C., et al.
Publicado: (2020)

Safe Blues: The case for virtual safe virus spread in the long-term fight against epidemics
por: Dandekar, Raj, et al.
Publicado: (2021)

Stem cell therapy without the cells
por: Maguire, Greg
Publicado: (2013)

Mesenchymal Stem Cells: Time to Change the Name!
por: Caplan, Arnold I.
Publicado: (2017)

Outlook for coeliac disease patients: towards bread wheat with hypoimmunogenic gluten by gene editing of α- and γ-gliadin gene families
por: Jouanin, Aurélie, et al.
Publicado: (2019)

Safe Use of Herbal Kelp Supplements
por: McGuffin, Michael, et al.
Publicado: (2007)

Conservation demands safe gene drive
por: Esvelt, Kevin M., et al.
Publicado: (2017)

Relevance of Pharmacogenomics to the Safe Use of Antimicrobials
por: Daly, Ann K.
Publicado: (2023)

Mesenchymal stem cells, implications for pain therapy
por: Trallori, Elena, et al.
Publicado: (2019)

Stem cell therapy for retinal ganglion cell degeneration
por: Cen, Ling-Ping, et al.
Publicado: (2018)

Breast Cancer Chemotherapy Can Be Administered Safely During the COVID‐19 Pandemic
Publicado: (2021)

The potential of stem cell-based therapy for retinal repair
por: Yu, Honghua, et al.
Publicado: (2014)

Towards stem cell therapies for skeletal muscle repair
por: Judson, Robert N., et al.
Publicado: (2020)

Mesenchymal stem cell therapy for severe COVID-19
por: Shi, Lei, et al.
Publicado: (2021)

Achieving safe surgery after COVID‐19 vaccination
por: Kovoor, Joshua G., et al.
Publicado: (2022)

Lives, Livelihoods and the Economy: India in Pandemic Times
por: Nayyar, Deepak
Publicado: (2020)

Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy
por: Das, Shipra, et al.
Publicado: (2023)

Stem cells: the new “model organism”
por: Drubin, David G., et al.
Publicado: (2017)

Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
por: Usategui-Martín, Ricardo, et al.
Publicado: (2020)

The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy
por: Naldini, Luigi, et al.
Publicado: (2022)

Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
por: Csöbönyeiová, Mária, et al.
Publicado: (2016)

When Is Replacement Feeding Safe for Infants of HIV-Infected Women?
por: John-Stewart, Grace C
Publicado: (2007)

Revitalising cancer trials post-pandemic: time for reform
por: Morton, Cienne, et al.
Publicado: (2023)

Two cancer stem cell‐targeted therapies in clinical trials as viewed from the standpoint of the cancer stem cell model
por: Caras, Ingrid W.
Publicado: (2020)

Neat1 in hematopoietic stem cells
por: Fallik, Noam, et al.
Publicado: (2017)

Stemness and plasticity of lung cancer cells: paving the road for better therapy
por: Luo, Judong, et al.
Publicado: (2014)

Dental pulp stem cells, a paracrine-mediated therapy for the retina
por: Mead, Ben, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3mjettkobo9sime1lebihbg65b